Gene · 5320
Papers3,288
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,288
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells. | BMC Complement Med Ther | 2023 | 37095470 | PubTator, text mining | PubMed |
The activities and mechanisms of intestinal microbiota metabolites of TCM herbal ingredients could be illustrated by a strategy integrating spectrum-effects, network pharmacology, metabolomics and molecular docking analysis: Platycodin D as an example. | Phytomedicine | 2023 | 37094423 | PubTator, text mining | PubMed |
| [Diagnostic value of lipoprotein-associated phospholipase A2 in OPBR combined with gallbladder cholesterol deposition]. | Zhonghua Yi Xue Za Zhi | 2023 | 37087406 | PubTator, text mining | PubMed |
Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma. | Naunyn Schmiedebergs Arch Pharmacol | 2023 | 37086280 | PubTator, text mining | PubMed |
| Mesenchymal-epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression. | J Transl Med | 2023 | 37076857 | PubTator, text mining | PubMed |
| Phospholipase A2 regulates autophagy in gouty arthritis: proteomic and metabolomic studies. | J Transl Med | 2023 | 37069596 | PubTator, text mining | PubMed |
| Gene expression changes in therapeutic ultrasound-treated venous leg ulcers. | Front Med (Lausanne) | 2023 | 37064037 | PubTator, text mining | PubMed |
| Deciphering the role of QPCTL in glioma progression and cancer immunotherapy. | Front Immunol | 2023 | 37063864 | PubTator, text mining | PubMed |
| Cellular Distribution of Secreted Phospholipase A2 in Lungs of IPF Patients and Its Inhibition in Bleomycin-Induced Pulmonary Fibrosis in Mice. | Cells | 2023 | 37048117 | PubTator, text mining | PubMed |
| Pitfalls of Thrombotic Microangiopathies in Children: Two Case Reports and Literature Review. | Diagnostics (Basel) | 2023 | 37046448 | PubTator, text mining | PubMed |
| Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis. | Arthritis Res Ther | 2023 | 37041650 | PubTator, text mining | PubMed |
| Comparison of cell subsets in chronic obstructive pulmonary disease and controls based on single-cell transcriptome sequencing. | Technol Health Care | 2023 | 37038777 | PubTator, text mining | PubMed |
| A network pharmacology and molecular docking approach in the exploratory investigation of the biological mechanisms of lagundi (Vitex negundo L.) compounds against COVID-19. | Genomics Inform | 2023 | 37037462 | PubTator, text mining | PubMed |
| Erratum: Lipid droplets and polyunsaturated fatty acid trafficking: Balancing life and death. | Front Cell Dev Biol | 2023 | 37035248 | PubTator, text mining | PubMed |
| Preferred practice patterns and review on rosacea. | Indian J Ophthalmol | 2023 | 37026270 | PubTator, text mining | PubMed |
| Identification of hub genes and pathways in lung metastatic colorectal cancer. | BMC Cancer | 2023 | 37024866 | PubTator, text mining | PubMed |
| Catalytically Active Snake Venom PLA2 Enzymes: An Overview of Its Elusive Mechanisms of Reaction. | J Med Chem | 2023 | 37018514 | PubTator, text mining | PubMed |
| A Bitter Taste Receptor as a Novel Molecular Target on Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma. | Pharmaceuticals (Basel) | 2023 | 36986488 | PubTator, text mining | PubMed |
| Biomarkers of Osteoarthritis-A Narrative Review on Causal Links with Metabolic Syndrome. | Life (Basel) | 2023 | 36983885 | PubTator, text mining | PubMed |
| Immunology of Multisystem Inflammatory Syndrome after COVID-19 in Children: A Review of the Current Evidence. | Int J Mol Sci | 2023 | 36982783 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5320/papers?page=18